Sainte Catherine, Institut du Cancer Avignon-Provence (ICAP), Becomes the First Center in Europe to Implement the Varian Latest Halcyon Advancements with Identify integration, PerfectKinetix Dynamic Couch and HyperSight for Personalized Radiotherapy
10.12.2025 09:00:00 CET | Business Wire | Press Release
Institut du Cancer Avignon-Provence (ICAP), and Varian, a Siemens Healthineers company, announced today the first European installation of the Halcyon version 5.0 radiotherapy platform, combined with IDENTIFY real-time motion management, and the PerfectKinetix Dynamic Couch. This milestone marks a significant step forward in delivering more precise, efficient, and personalized radiotherapy, while enhancing the overall patient experience.
The latest evolution of Varian’s Halcyon platform brings together enhanced patient positioning, real-time motion management with IDENTIFY, and embedded high-quality HyperSight imaging. ICAP’s adoption of this ecosystem reflects its commitment to offering patients in the region access to the latest innovations in radiation oncology.
Advancing Personalized Care
The combination of Halcyon 5.0 and IDENTIFY 5.0 enables clinicians to deliver treatment more effectively by supporting individualized care plans.
- IDENTIFY* integration is designed to improve positioning options, provide automated beam control, and simplify workflows.
- Embedded HyperSight* shortens imaging sessions with scans that are better, faster, bigger, and have shown to make a difference in patient treatments.
- The new PerfectKinetix Dynamic Couch* accelerates patient positioning and aims to improve comfort.
Together these innovations aim to streamline complex workflows and help clinicians personalize treatment with greater confidence.
Enhancing the Patient Experience
Halcyon was built to maximize efficiency and treat more effectively. With these latest advancements, Halcyon elevates the patient experience through shorter imaging sessions, streamlined positioning workflows, and smooth single motion couch adjustment. For patients, these improvements are intended to reduce immobilization time, enhance comfort and minimize stress during treatment.
The system is now fully operational at ICAP, which has already begun treating its first patients using the Halcyon 5.0 setup.
“The combined functionalities of Halcyon 5.0 and Identify 5.0 enable clinicians to deliver high-precision treatments with greater confidence and safety, while enhancing the patient experience through improved efficiency,” said Dr Catherine Khamphan, Medical physicist and Head of Research and Development at ICAP. “It is impressive to see how Varian has succeeded in responding to the needs of therapists, physicists, and oncologists with this new radiotherapy platform.”
For Dr Pierre Trémolières, Radiation Oncologist and GI specialist at ICAP, “These innovations could open the door to new treatment possibilities in our center, such as dose escalation in adaptive radiotherapy for pancreatic cancer while preserving surrounding organs at risk. Treatment options for pancreatic cancer remain limited, and offering new therapeutic strategies is crucial.”
“We are proud to see Institut du Cancer Avignon-Provence, lead the way as the first center in Europe to adopt the Halcyon 5.0 ecosystem,” said Virve Sarja, Head of Varian for Europe, Middle East and Africa. “This installation reflects our commitment to supporting cancer centers and clinical teams with innovative solutions that elevate precision, improve the patient experience, and make personalized care more accessible. Together, we are shaping a future where radiotherapy is more accessible, more patient-centered, and aligned with the highest standards of care.”
© 2025 VARIAN MEDICAL SYSTEMS, INC. All trademarks are the property of their respective owners.
- *Automated beam hold requires the optional Connect IDENTIFY feature.
- *An optional feature on Halcyon.
"Halcyon 5.0 and Identify 5.0 are not available for sale in all markets."
QR700032647
About Sainte-Catherine - Institut du Cancer - Avignon-Provence
Founded in 1946, Sainte-Catherine is a medical institution specializing in cancer screening and treatment. As a private, non-profit healthcare organization recognized as being of public interest, Sainte-Catherine fulfills public service missions in oncology including care, prevention, research, and education.
With the expertise of its clinical teams, advanced technical capabilities, and active clinical research programs, Sainte-Catherine ranks among the leading cancer centers in France.
The institution has been ISO 9001 certified since 2018 for its clinical trial investigations.
Sainte-Catherine has been an affiliated member of Unicancer since 202.
Key Figures | ||
• 19 500 patients treated per year annually | • 2 700 new patients | |
• 48 000 radiotherapy sessions per year | • 20 500 chemotherapy sessions per year | |
• 36 000 medical consultations annually | • 101 inpatient beds and 59 outpatient places | |
About Varian, a Siemens Healthineers company
At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20251210623911/en/
Contacts
Press Contact
Kristin Corey
Varian Corporate Communications
Kristin.Corey@varian.com
Karine CHESNEL
Responsable communication & mécénat Sainte-Catherine, Institut du Cancer Avignon
- Provence
Tél. : +33 (0)4 90 27 60 50
k.chesnel@isc84.org
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
UPS Announces Agreement to Acquire Smartways Logistics17.11.2026 22:00:00 CET | Press Release
UPS (NYSE: UPS) today announced it has entered into an agreement to acquire Smartways Logistics (Smartways), a healthcare logistics provider serving Australia and New Zealand. Once completed, the acquisition will enhance UPS Healthcare’s time-critical transportation capabilities in the region. Smartways enables healthcare customers to move critical shipments quickly and reliably, with specialized services for life sciences, medical devices, clinical trials and radiopharmaceuticals. The acquisition will build on UPS Healthcare’s ability to deliver for customers with urgent and complex logistics needs, while expanding the services available in Australia, New Zealand and the Asia Pacific region. “As healthcare becomes increasingly complex, logistics plays an even more critical role. It takes specialized capabilities and precision at every step to help vital healthcare products reach patients safely, reliably and when they’re needed,” said Wilfredo Ramos, UPS EVP and Chief International, H
Spatial Announces Release 2027 1.0 with New Enhancements Across CAD Modeling, Interoperability, Data Preparation, and Meshing17.11.2026 20:10:00 CET | Press Release
Spatial Corp., the leading software development kit provider for design, manufacturing and engineering solutions and a subsidiary of Dassault Systèmes, today announced the availability of its 2027 1.0 Release. This latest release introduces new capabilities and enhancements across Spatial's 3D ACIS Modeler, CGM Modeler, 3D InterOp, Data Prep and CSM/CVM product lines. Designed to improve efficiency, flexibility and robustness across CAD modeling, interoperability, data preparation and simulation workflows, the release delivers enhanced geometry processing, expanded modeling capabilities, improved CAD translation and advances in mesh generation for a better workflow coverage. 3D ACIS Modeler Enhanced Blending (Filleting) The 3D ACIS Modeler introduces support for asymmetric fixed-width blends with a conic cross-section, providing users with finer control over smooth transitions between edges. This enhancement builds on the symmetric fixed-width blend with a conic cross-section capabilit
Global EV Alliance Survey: EV Drivers Identify Myths and Misconceptions as the Biggest Barrier to Adoption17.11.2026 19:00:00 CET | Press Release
Myths and misconceptions about electric cars, from battery lifespan and fire risk to grid collapse, are the biggest barrier to EV adoption, according to respondents to the annual Global EV Driver Survey. The 2026 survey draws on responses from more than 29,500 EV drivers across 34 countries. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261117539716/en/ MYTHS. Battery lifespan (72%), fire risk (58%) and grid collapse (45%) top the list of EV myths reported by respondents to the 2026 Global EV Driver Survey, which gathered responses from more than 29,500 EV drivers across 34 countries. “The EV transition is not just an infrastructure or affordability challenge. It is also an information challenge. Outdated information and misconceptions continue to influence decisions long after the technology has moved on,” says Ellen Hiep, from the Steering Committee of the Global EV Alliance (GEVA). Myths the greatest barrier Asked to ide
KILL Trulioo’s Global Risk Platform Unlocks Device and Behavioral Intelligence Via Bureau Partnership17.11.2026 19:00:00 CET | Press Release
Trulioo requests that their press release NewsItemId: 20261117163539 “Trulioo’s Global Risk Platform Unlocks Device and Behavioral Intelligence Via Bureau Partnership” be killed. The release was issued in error by Trulioo.
TreeFrog Therapeutics Appoints James Sterling as Chief Financial Officer17.11.2026 18:04:00 CET | Press Release
TreeFrog Therapeutics, a biotechnology company developing scalable cell therapies built on its proprietary C-Stem™ technology, today announced the appointment of James Sterling as Chief Financial Officer, effective November 1, 2026. James joins TreeFrog’s executive leadership team and reports to Mark Rothera, President and Chief Executive Officer. He oversees finance, investor relations and corporate development as the company enters its next phase of growth. “I am delighted to welcome James to TreeFrog. James brings a valuable combination of biotech CFO and Wall Street experience that supports our ambitions to develop TreeFrog into a key enabling partner and drug developer in the regenerative medicines field,” said Mark Rothera, President and Chief Executive Officer of TreeFrog Therapeutics. James contributes deep experience in corporate finance, capital markets and strategic planning across therapeutics and diagnostics. Recently, he served as Chief Financial Officer of Bluebird Bio (
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom